Airway microbial dysbiosis in asthmatic patients: A target for prevention and treatment?

Journal of Allergy and Clinical Immunology

Volumn 139, Issue 4, 2017, Pages 1071-1081

  Chung, Kian Fan ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

airway microbiome; Airway microbiota; asthma; gut microbiota; gut lung axis; microbial dysbiosis

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; PREBIOTIC AGENT; PROBIOTIC AGENT;

AIRWAY MICROBIAL DYSBIOSIS; ASTHMA; DRUG EFFICACY; DYSBIOSIS; ENVIRONMENTAL FACTOR; HUMAN; INTESTINE FLORA; LUNG; MICROBIAL COMMUNITY; MICROBIOME; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SENSITIZATION; ANIMAL; HYPERSENSITIVITY; IMMUNOLOGY; MICROBIOLOGY; MOUSE; PATHOPHYSIOLOGY;

ANIMALS; ASTHMA; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HUMANS; HYPERSENSITIVITY; LUNG; MICE;

EID: 85017308940     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2017.02.004     Document Type: Review

References (86)

1. 1 Cazzola, M., Matera, M.G., Rossi, F., Bronchial hyperresponsiveness and bacterial respiratory infections. Clin Ther 13 (1991), 157–171.
2. 2 Wood, L.G., Simpson, J.L., Hansbro, P.M., Gibson, P.G., Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia. Free Radic Res 44 (2010), 146–154.
3. 3 Zhang, Q., Illing, R., Hui, C.K., Downey, K., Carr, D., Stearn, M., et al. Bacteria in sputum of stable severe asthma and increased airway wall thickness. Respir Res, 13, 2012, 35.
4. 4 Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
5. 5 Palm, N.W., de Zoete, M.R., Flavell, R.A., Immune-microbiota interactions in health and disease. Clin Immunol 159 (2015), 122–127.
6. 6 Gilbert, J.A., Quinn, R.A., Debelius, J., Xu, Z.Z., Morton, J., Garg, N., et al. Microbiome-wide association studies link dynamic microbial consortia to disease. Nature 535 (2016), 94–103.
7. 7 Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., et al. Disordered microbial communities in asthmatic airways. PLoS One, 5, 2010, e8578.
8. 8 Hauptmann, M., Schaible, U.E., Linking microbiota and respiratory disease. FEBS Lett 590 (2016), 3721–3738.
9. 9 Strachan, D.P., Hay fever, hygiene, and household size. BMJ 299 (1989), 1259–1260.
10. 10 Gensollen, T., Iyer, S.S., Kasper, D.L., Blumberg, R.S., How colonization by microbiota in early life shapes the immune system. Science 352 (2016), 539–544.
11. 11 Lefaudeux, D., De Meulder, B., Loza, M.J., Peffer, N., Rowe, A., Baribaud, F., et al. U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics. J Allergy Clin Immunol, 2016 [Epub ahead of print].
12. 12 Chung, K.F., Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies. J Intern Med 279 (2016), 192–204.
13. 13 Woodruff, P.G., Modrek, B., Choy, D.F., Jia, G., Abbas, A.R., Ellwanger, A., et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180 (2009), 388–395.
14. 14 Lambrecht, B.N., Hammad, H., The immunology of asthma. Nat Immunol 16 (2015), 45–56.
15. 15 Bilate, A.M., Lafaille, J.J., Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu Rev Immunol 30 (2012), 733–758.
16. 16 Curotto de Lafaille, M.A., Kutchukhidze, N., Shen, S., Ding, Y., Yee, H., Lafaille, J.J., Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29 (2008), 114–126.
17. 17 Mamessier, E., Nieves, A., Lorec, A.M., Dupuy, P., Pinot, D., Pinet, C., et al. T-cell activation during exacerbations: a longitudinal study in refractory asthma. Allergy 63 (2008), 1202–1210.
18. 18 Hartl, D., Koller, B., Mehlhorn, A.T., Reinhardt, D., Nicolai, T., Schendel, D.J., et al. Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 119 (2007), 1258–1266.
19. 19 Chung, K.F., Wenzel, S.E., Brozek, J.L., Bush, A., Castro, M., Sterk, P.J., et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 43 (2014), 343–373.
20. 20 Kuo, C.S., Pavlidis, S., Loza, M., Baribaud, F., Rowe, A., Pandis, I., et al. Th2 and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in UBIOPRED. Eur Respir J, 49, 2017 [In press].
21. 21 Bassis, C.M., Erb-Downward, J.R., Dickson, R.P., Freeman, C.M., Schmidt, T.M., Young, V.B., et al. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio, 6, 2015, e00037.
22. 22 Venkataraman, A., Bassis, C.M., Beck, J.M., Young, V.B., Curtis, J.L., Huffnagle, G.B., et al. Application of a neutral community model to assess structuring of the human lung microbiome. MBio, 6, 2015.
23. 23 Dickson, R.P., Erb-Downward, J.R., Huffnagle, G.B., Homeostasis and its disruption in the lung microbiome. Am J Physiol Lung Cell Mol Physiol 309 (2015), L1047–L1055.
24. 24 Schuijt, T.J., Lankelma, J.M., Scicluna, B.P., de Sousa e Melo, F., Roelofs, J.J., de Boer, J.D., et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 65 (2016), 575–583.
25. 25 Sze, M.A., Tsuruta, M., Yang, S.W., Oh, Y., Man, S.F., Hogg, J.C., et al. Changes in the bacterial microbiota in gut, blood, and lungs following acute LPS instillation into mice lungs. PLoS One, 9, 2014, e111228.
26. 26 He, Y., Wen, Q., Yao, F., Xu, D., Huang, Y., Wang, J., Gut-lung axis: the microbial contributions and clinical implications. Crit Rev Microbiol 43 (2017), 81–95.
27. 27 Marsland, B.J., Trompette, A., Gollwitzer, E.S., The gut-lung axis in respiratory disease. Ann Am Thorac Soc 12:suppl 2 (2015), S150–S156.
28. 28 Riedler, J., Braun-Fahrlander, C., Eder, W., Schreuer, M., Waser, M., Maisch, S., et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 358 (2001), 1129–1133.
29. 29 Fall, T., Lundholm, C., Ortqvist, A.K., Fall, K., Fang, F., Hedhammar, A., et al. Early exposure to dogs and farm animals and the risk of childhood asthma. JAMA Pediatr, 169, 2015, e153219.
30. 30 Ownby, D.R., Johnson, C.C., Peterson, E.L., Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. JAMA 288 (2002), 963–972.
31. 31 Braun-Fahrlander, C., Riedler, J., Herz, U., Eder, W., Waser, M., Grize, L., et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 347 (2002), 869–877.
32. 32 Stein, M.M., Hrusch, C.L., Gozdz, J., Igartua, C., Pivniouk, V., Murray, S.E., et al. Innate immunity and asthma risk in Amish and Hutterite farm children. N Engl J Med 375 (2016), 411–421.
33. 33 Silvers, K.M., Frampton, C.M., Wickens, K., Pattemore, P.K., Ingham, T., Fishwick, D., et al. Breastfeeding protects against current asthma up to 6 years of age. J Pediatr 160 (2012), 991–996.e1.
34. 34 Waser, M., Michels, K.B., Bieli, C., Floistrup, H., Pershagen, G., von Mutius, E., et al. Inverse association of farm milk consumption with asthma and allergy in rural and suburban populations across Europe. Clin Exp Allergy 37 (2007), 661–670.
35. 35 Valkonen, M., Wouters, I.M., Taubel, M., Rintala, H., Lenters, V., Vasara, R., et al. Bacterial exposures and associations with atopy and asthma in children. PLoS One, 10, 2015, e0131594.
36. 36 Lynch, S.V., Wood, R.A., Boushey, H., Bacharier, L.B., Bloomberg, G.R., Kattan, M., et al. Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children. J Allergy Clin Immunol 134 (2014), 593–601.e12.
37. 37 Lodge, C.J., Tan, D.J., Lau, M.X., Dai, X., Tham, R., Lowe, A.J., et al. Breastfeeding and asthma and allergies: a systematic review and meta-analysis. Acta Paediatr 104 (2015), 38–53.
38. 38 Gomez-Gallego, C., Garcia-Mantrana, I., Salminen, S., Collado, M.C., The human milk microbiome and factors influencing its composition and activity. Semin Fetal Neonatal Med 21 (2016), 400–405.
39. 39 Rogier, E.W., Frantz, A.L., Bruno, M.E., Wedlund, L., Cohen, D.A., Stromberg, A.J., et al. Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression. Proc Natl Acad Sci U S A 111 (2014), 3074–3079.
40. 40 Walker, W.A., Iyengar, R.S., Breast milk, microbiota, and intestinal immune homeostasis. Pediatr Res 77 (2015), 220–228.
41. 41 Schuijs, M.J., Willart, M.A., Vergote, K., Gras, D., Deswarte, K., Ege, M.J., et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science 349 (2015), 1106–1110.
42. 42 Depner, M., Ege, M.J., Cox, M.J., Dwyer, S., Walker, A.W., Birzele, L.T., et al. Bacterial microbiota of the upper respiratory tract and childhood asthma. J Allergy Clin Immunol, 2016 [Epub ahead of print].
43. 43 Arrieta, M.C., Stiemsma, L.T., Dimitriu, P.A., Thorson, L., Russell, S., Yurist-Doutsch, S., et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med, 7, 2015, 307ra152.
44. 44 Teo, S.M., Mok, D., Pham, K., Kusel, M., Serralha, M., Troy, N., et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe 17 (2015), 704–715.
45. 45 Bisgaard, H., Hermansen, M.N., Bonnelykke, K., Stokholm, J., Baty, F., Skytt, N.L., et al. Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study. BMJ, 341, 2010, c4978.
46. 46 Bisgaard, H., Hermansen, M.N., Buchvald, F., Loland, L., Halkjaer, L.B., Bonnelykke, K., et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 357 (2007), 1487–1495.
47. 47 Fujimura, K.E., Sitarik, A.R., Havstad, S., Lin, D.L., Levan, S., Fadrosh, D., et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med 22 (2016), 1187–1191.
48. 48 Huang, Y.J., Nelson, C.E., Brodie, E.L., Desantis, T.Z., Baek, M.S., Liu, J., et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 127 (2011), 372–381 e1-3.
49. 49 Denner, D.R., Sangwan, N., Becker, J.B., Hogarth, D.K., Oldham, J., Castillo, J., et al. Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways. J Allergy Clin Immunol 137 (2016), 1398–1405.e3.
50. 50 Simpson, J.L., Daly, J., Baines, K.J., Yang, I.A., Upham, J.W., Reynolds, P.N., et al. Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma. Eur Respir J 47 (2016), 792–800.
51. 51 Huang, Y.J., Nariya, S., Harris, J.M., Lynch, S.V., Choy, D.F., Arron, J.R., et al. The airway microbiome in patients with severe asthma: associations with disease features and severity. J Allergy Clin Immunol 136 (2015), 874–884.
52. 52 Marri, P.R., Stern, D.A., Wright, A.L., Billheimer, D., Martinez, F.D., Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol 131 (2013), 346–352 e1-3.
53. 53 Durack, J., Lynch, S.V., Nariya, S., Bhakta, N.R., Beigelman, A., Castro, M., et al. Features of the bronchial bacterial microbiome associated with atopy, asthma and responsiveness to inhaled corticosteroid treatment. J Allergy Clin Immunol, 2016 [Epub ahead of print].
54. 54 Green, B.J., Wiriyachaiporn, S., Grainge, C., Rogers, G.B., Kehagia, V., Lau, L., et al. Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma. PLoS One, 9, 2014, e100645.
55. 55 Zhang, Q., Cox, M., Liang, Z., Brinkmann, F., Cardenas, P.A., Duff, R., et al. Airway microbiota in severe asthma and relationship to asthma severity and phenotypes. PLoS One, 11, 2016, e0152724.
56. 56 Sverrild, A., Kiilerich, P., Brejnrod, A., Pedersen, R., Porsbjerg, C., Bergqvist, A., et al. Eosinophilic airway inflammation in asthma is associated with an altered airway microbiome. J Allergy Clin Immunol, 2016 [Epub ahead of print].
57. 57 Goleva, E., Jackson, L.P., Harris, J.K., Robertson, C.E., Sutherland, E.R., Hall, C.F., et al. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med 188 (2013), 1193–1201.
58. 58 Molyneaux, P.L., Mallia, P., Cox, M.J., Footitt, J., Willis-Owen, S.A., Homola, D., et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 188 (2013), 1224–1231.
59. 59 Wagner Mackenzie, B., Waite, D.W., Hoggard, M., Douglas, R.G., Taylor, M.W., Biswas, K., Bacterial community collapse: a meta-analysis of the sinonasal microbiota in chronic rhinosinusitis. Environ Microbiol 19 (2017), 381–392.
60. 60 Gibeon, D., Batuwita, K., Osmond, M., Heaney, L.G., Brightling, C.E., Niven, R., et al. Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society Difficult Asthma Registry Patient cohort according to BMI. Chest 143 (2013), 406–414.
61. 61 Shore, S.A., Cho, Y., Obesity and asthma: microbiome-metabolome interactions. Am J Respir Cell Mol Biol 54 (2016), 609–617.
62. 62 Kim, H.Y., Lee, H.J., Chang, Y.J., Pichavant, M., Shore, S.A., Fitzgerald, K.A., et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med 20 (2014), 54–61.
63. 63 Nembrini, C., Sichelstiel, A., Kisielow, J., Kurrer, M., Kopf, M., Marsland, B.J., Bacterial-induced protection against allergic inflammation through a multicomponent immunoregulatory mechanism. Thorax 66 (2011), 755–763.
64. 64 Debarry, J., Garn, H., Hanuszkiewicz, A., Dickgreber, N., Blumer, N., von Mutius, E., et al. Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties. J Allergy Clin Immunol 119 (2007), 1514–1521.
65. 65 Fujimura, K.E., Demoor, T., Rauch, M., Faruqi, A.A., Jang, S., Johnson, C.C., et al. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc Natl Acad Sci U S A 111 (2014), 805–810.
66. 66 Herbst, T., Sichelstiel, A., Schar, C., Yadava, K., Burki, K., Cahenzli, J., et al. Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am J Respir Crit Care Med 184 (2011), 198–205.
67. 67 Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504 (2013), 446–450.
68. 68 Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly, Y.M., et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341 (2013), 569–573.
69. 69 Tremaroli, V., Backhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489 (2012), 242–249.
70. 70 Trompette, A., Gollwitzer, E.S., Yadava, K., Sichelstiel, A.K., Sprenger, N., Ngom-Bru, C., et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20 (2014), 159–166.
71. 71 Gollwitzer, E.S., Saglani, S., Trompette, A., Yadava, K., Sherburn, R., McCoy, K.D., et al. Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat Med 20 (2014), 642–647.
72. 72 McKinley, L., Alcorn, J.F., Peterson, A., Dupont, R.B., Kapadia, S., Logar, A., et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 181 (2008), 4089–4097.
73. 73 Ramesh, R., Kozhaya, L., McKevitt, K., Djuretic, I.M., Carlson, T.J., Quintero, M.A., et al. Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J Exp Med 211 (2014), 89–104.
74. 74 Tait Wojno, E.D., Artis, D., Emerging concepts and future challenges in innate lymphoid cell biology. J Exp Med 213 (2016), 2229–2248.
75. 75 Yadav, V., Gaisford, S., Merchant, H.A., Basit, A.W., Colonic bacterial metabolism of corticosteroids. Int J Pharm 457 (2013), 268–274.
76. 76 Brusselle, G.G., Vanderstichele, C., Jordens, P., Deman, R., Slabbynck, H., Ringoet, V., et al. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax 68 (2013), 322–329.
77. 77 Johnston, S.L., Szigeti, M., Cross, M., Brightling, C., Chaudhuri, R., Harrison, T., et al. Azithromycin for Acute Exacerbations of Asthma: the AZALEA randomized clinical trial. JAMA Intern Med 176 (2016), 1630–1637.
78. 78 Ferrer, M., Mendez-Garcia, C., Rojo, D., Barbas, C., Moya, A., Antibiotic use and microbiome function. Biochem Pharmacol, 2016 [Epub ahead of print].
79. 79 Segal, L.N., Clemente, J.C., Wu, B.G., Wikoff, W.R., Gao, Z., Li, Y., et al. Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung. Thorax 72 (2017), 13–22.
80. 80 Russell, S.L., Gold, M.J., Hartmann, M., Willing, B.P., Thorson, L., Wlodarska, M., et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep 13 (2012), 440–447.
81. 81 Vliagoftis, H., Kouranos, V.D., Betsi, G.I., Falagas, M.E., Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol 101 (2008), 570–579.
82. 82 Chen, Y.S., Jan, R.L., Lin, Y.L., Chen, H.H., Wang, J.Y., Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatr Pulmonol 45 (2010), 1111–1120.
83. 83 Gutkowski, P., Madaliński, K., Grek, M., Dmeńska, H., Syczewska, M., Michałkiewicz, J., Clinical immunology: effect of orally administered probiotic strains Lactobacillus and Bifidobacterium in children with atopic asthma. Central Eur J Immunol 35 (2011), 233–238.
84. 84 van de Pol, M.A., Lutter, R., Smids, B.S., Weersink, E.J., van der Zee, J.S., Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics. Allergy 66 (2011), 39–47.
85. 85 Thorburn, A.N., O'Sullivan, B.J., Thomas, R., Kumar, R.K., Foster, P.S., Gibson, P.G., et al. Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease. Thorax 65 (2010), 1053–1060.
86. 86 Maslowski, K.M., Vieira, A.T., Ng, A., Kranich, J., Sierro, F., Yu, D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461 (2009), 1282–1286.